RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL — Class II drug recall D-0898-2022
Completed recall by Olympia Compounding Pharmacy dba Olympia Pharmacy, reported 2022-06-01, distributed nationwide. Lack of assurance of sterility.
| Recall number | D-0898-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL, United States |
| Recall initiated | 2022-05-09 |
| Classified | 2022-05-25 |
| Reported by FDA | 2022-06-01 |
| Distributed | Nationwide (US) |
| Quantity | 482 vials |
| Reason classes | sterility |
| NDC | 73198-0015-03, 73198-0015-10 |
| Lot numbers | B24E09-22, B24F09-22 |
| Expiration dates | 2023-02-09 |
Product
RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL, packaged as a) 2.5 mL Multi Dose vial, NDC 73198-0015-03; b) 10 mL Multi Dose vial, NDC 73198-0015-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835
Reason for recall
Lack of assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0898-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.